GlassScriptPhysician profile
Michael I Orestes
NPI 1568623445
$12,070.85
in general payments reported to CMS, 2019-2025
5 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,069 · 2020: $363 · 2021: $249 · 2022: $134 · 2023: $7,042 · 2024: $1,373 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $3,614 · Food and Beverage: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $3,613.88 |
| Food and Beverage | $1,141.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,877.45 | 2023 | Da Vinci Sp, Da Vinci Surgical System |
| Inspire Medical Systems, INC. | $4,931.61 | 2019-2025 | Inspire |
| Medtronic, INC. | $133.92 | 2022 | |
| Stryker Corporation | $108.16 | 2024 | Na, Stryker Varispeed |
| Atos Medical INC | $19.71 | 2024 | Provox Life Home Hme |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Orestes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.